The Maxwell Centre at the ¹ú¼ÊÃ×À¼¶ÔÕó¿ÆĪ and , leaders in data and AI, are launching a partnership aimed at accelerating healthcare innovation through enhanced access to advanced analytics.
¹ú¼ÊÃ×À¼¶ÔÕó¿ÆĪ's Experimental Medicine Initiative, working with AstraZeneca and GSK, is training specialists who can work out at an earlier stage of clinical trials if a treatment is likely to succeed.
GSK, the ¹ú¼ÊÃ×À¼¶ÔÕó¿ÆĪ and ¹ú¼ÊÃ×À¼¶ÔÕó¿ÆĪ University Hospitals NHS Foundation Trust today announce their Strategic Partnership, with the long-term ambition to jointly deliver new medicine to patients in the next 5-10 years.
¹ú¼ÊÃ×À¼¶ÔÕó¿ÆĪ has been part of a successful £16 million bid to work with the MRC, GSK and four other UK universities in a unique open innovation research initiative aiming to improve scientists’ understanding of inflammatory diseases that present a serious burden to patients.
AstraZeneca and the ¹ú¼ÊÃ×À¼¶ÔÕó¿ÆĪ today announced three new joint schemes to support more than 80 PhD scholarships and eight clinical lectureships over the next five years spanning translational science, basic and clinical research. Two of the schemes are co-funded by the NIHR ¹ú¼ÊÃ×À¼¶ÔÕó¿ÆĪ Biomedical Research Centre, a partnership between ¹ú¼ÊÃ×À¼¶ÔÕó¿ÆĪ University Hospitals and ¹ú¼ÊÃ×À¼¶ÔÕó¿ÆĪ.
© 2025 ¹ú¼ÊÃ×À¼¶ÔÕó¿ÆĪ